Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000827809-18-000009
Filing Date
2018-04-30
Accepted
2018-04-30 08:31:21
Documents
3
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A nvln-12312017x10ka.htm 10-K/A 1088123
2 EXHIBIT 31.1 nvln-12312017xex311.htm EX-31.1 6140
3 EXHIBIT 31.2 nvln-12312017xex312.htm EX-31.2 5863
  Complete submission text file 0000827809-18-000009.txt   1101509
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-17082 | Film No.: 18786807
SIC: 2834 Pharmaceutical Preparations